Search

Displaying results 6111 - 6120 of 6279 in total
  1. Drug

    9MW3011

    go.drugbank.com/drugs/DB24999
    Investigational

    The drug is an anti-TMPRSS6 (Transmembrane Serine Protease 6, also known as Matriptase-2) monoclonal antibody.[L54591, L54596]

  2. Drug

    Fibracillin

    go.drugbank.com/drugs/DB21302
    Experimental

    The usage of the INN stem '-cillin' in the name indicates that Fibracillin is a antibiotic, 6-aminopenicillanic acid derivative. Fibracillin has a monoisotopic molecular weight of 545.14 Da.

  3. Drug

    Lenampicillin

    go.drugbank.com/drugs/DB20342
    Experimental

    The usage of the INN stem '-cillin' in the name indicates that Lenampicillin is a antibiotic, 6-aminopenicillanic acid derivative. Lenampicillin has a monoisotopic molecular weight of 461.13 Da.

    Categories: Penicillin G
  4. Drug

    Piroxicillin

    go.drugbank.com/drugs/DB20772
    Experimental

    The usage of the INN stem '-cillin' in the name indicates that Piroxicillin is a antibiotic, 6-aminopenicillanic acid derivative. Piroxicillin has a monoisotopic molecular weight of 672.14 Da.

  5. Drug

    Fuzlocillin

    go.drugbank.com/drugs/DB20833
    Experimental

    The usage of the INN stem '-cillin' in the name indicates that Fuzlocillin is a antibiotic, 6-aminopenicillanic acid derivative. Fuzlocillin has a monoisotopic molecular weight of 570.15 Da.

    Categories: Penicillin G
  6. Drug

    Suncillin

    go.drugbank.com/drugs/DB20578
    Experimental

    The usage of the INN stem '-cillin' in the name indicates that Suncillin is a antibiotic, 6-aminopenicillanic acid derivative. Suncillin has a monoisotopic molecular weight of 429.07 Da.

    Categories: Penicillin G
  7. Drug

    DL-alpha-Tocopherol

    go.drugbank.com/drugs/DB14476
    ApprovedInvestigational

    Mixtures: Eden With Vitamins A, C, and ECategories: Vitamin E
  8. Drug

    Fosdenopterin

    go.drugbank.com/drugs/DB16628
    Approved

    In 2009 a recombinant, E. coli-produced cPMP was granted orphan drug designation by the FDA, becoming the first therapeutic option for patients with MoCD type A.

  9. Drug

    Reltecimod

    go.drugbank.com/drugs/DB16687
    Investigational

    Reltecimod is under investigation in clinical trial NCT02469857 (Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections).

    Categories: Antigens, Differentiation, T-Lymphocyte, Costimulatory and Inhibitory T-Cell Receptors
  10. Drug

    Quinacillin

    go.drugbank.com/drugs/DB20283
    Experimental

    The usage of the INN stem '-cillin' in the name indicates that Quinacillin is a antibiotic, 6-aminopenicillanic acid derivative. Quinacillin has a monoisotopic molecular weight of 416.08 Da.